NEOHEME Trademark

Trademark Overview


On Wednesday, January 25, 2017, a trademark application was filed for NEOHEME with the United States Patent and Trademark Office. The USPTO has given the NEOHEME trademark a serial number of 79211725. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 9, 2024. This trademark is owned by Siemens Healthcare GmbH. The NEOHEME trademark is filed in the Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratories, namely, chemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposes, namely, for the detection, analysis and treatment of cancer; cultures of microorganisms for medical and veterinary use

Medical services, in particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicine, veterinary medicine and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic, theranostic, prognostic and analytical services, including molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases

Scientific and technological services, namely, medical testing in the fields of identification, analysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identification, analysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software
neoheme

General Information


Serial Number79211725
Word MarkNEOHEME
Filing DateWednesday, January 25, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 9, 2024
Registration Number5383046
Registration DateTuesday, January 23, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratories, namely, chemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposes, namely, for the detection, analysis and treatment of cancer; cultures of microorganisms for medical and veterinary use
Goods and ServicesMedical services, in particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicine, veterinary medicine and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic, theranostic, prognostic and analytical services, including molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases
Goods and ServicesScientific and technological services, namely, medical testing in the fields of identification, analysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identification, analysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 9, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 9, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSiemens Healthcare GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameSiemens Healthcare GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameSiemens Healthcare GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Tuesday, July 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 11, 2017ASSIGNED TO EXAMINER
Thursday, July 6, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 17, 2017REFUSAL PROCESSED BY MPU
Thursday, August 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 28, 2017ASSIGNED TO LIE
Thursday, July 13, 2017NON-FINAL ACTION WRITTEN
Friday, July 14, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, July 15, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, July 18, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 4, 2017REFUSAL PROCESSED BY IB
Wednesday, August 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 20, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, October 3, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 30, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 20, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 20, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, September 20, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 2, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2018REGISTERED-PRINCIPAL REGISTER
Monday, April 23, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, January 23, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 9, 2024CANCELLED SECTION 71
Friday, September 24, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2018FINAL DISPOSITION PROCESSED
Wednesday, May 2, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 15, 2018FINAL DECISION TRANSACTION PROCESSED BY IB